Morgan Stanley Cuts Alexandria Real Estate Equities Price Target

Analysts lower price target on REIT stock to $54 from $55

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Morgan Stanley has lowered its price target on shares of Alexandria Real Estate Equities (NYSE:ARE) from $55 to $54, while maintaining an "equal weight" rating on the stock. The real estate investment trust's stock has faced pressure in recent months amid broader market volatility.

Why it matters

Alexandria Real Estate Equities is a major player in the life sciences and technology real estate sector, owning and operating specialized campuses that support innovation and research. As a bellwether REIT, changes to its stock price target can signal broader trends in the commercial real estate market.

The details

In a report released on Monday, Morgan Stanley analysts cited the ongoing challenges facing the REIT, including a drop in its share price from a 52-week high of $105.14 to a current level around $56. The analysts maintained their "equal weight" rating on the stock, indicating they see limited upside potential at current levels.

  • Morgan Stanley released its updated price target on February 10, 2026.

The players

Morgan Stanley

A global financial services firm that provides investment banking, securities, wealth management and investment management services.

Alexandria Real Estate Equities

A real estate investment trust that specializes in the ownership, development and management of collaborative life science and technology campuses.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The lowered price target on Alexandria Real Estate Equities reflects broader concerns about the commercial real estate market, particularly for specialized properties that support the life sciences and technology sectors. As a bellwether REIT, the company's performance can provide insights into the health of these important industries.